Table 2.
Mean TAC and ROS values in CML patients depending on the response to TKIs treatment
|
Number |
TAC (mM) |
ROS (FI) |
TAC (mM) |
ROS (FI) |
|
|
PR-I |
26 |
0.26±0.045 |
10.377±0.281 |
0.248±0.032 |
10.328±0.187 |
|
SR-I |
3 |
0.236±0.12 |
10.746±1.631 |
||
|
MMR-I |
21 |
0.236±0.05 |
10.208±0.209 |
||
|
PR-D |
6 |
0.153±0.098 |
10.79±0.721 |
0.165±0.055 |
10.71±0.348 |
|
SR-D |
0 |
- |
- |
||
|
MMR-D |
11 |
0.171±0.07 |
10.666±0.396 |
||
|
PR-N |
10 |
0.28±0.078 |
10.58±0.546 |
0.246±0.062 |
10.644±0.414 |
|
SR-N |
1 |
0 |
9.22±0 |
||
|
MMR-N |
5 |
0.18±0.11 |
10.772±0.675 |